Clinical Trial Update: iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Gallium-68-deferoxamine for imaging in pulmonary aspergillosis, including chronic pulmonary aspergillosis and allergic broncho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Bronchopulmonary Aspergillosis
• Pulmonary Aspergillosis

Drugs mentioned

• Gallium-68-deferoxamine (gallium-68 deferoxamine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Pulmonary Aspergillosis, Chronic Pulmonary Aspergillosis | Phase 2 | Status: RECRUITING